PUF60-SCRIB fusion transcript in a patient with 8q24.3 microdeletion and atypical Verheij syndrome.
Adolescent
Chromosome Breakpoints
Chromosome Deletion
Chromosomes, Human, Pair 8
/ genetics
Coloboma
/ genetics
Female
Gene Fusion
Humans
Intellectual Disability
/ genetics
Megalencephaly
/ genetics
Membrane Proteins
/ genetics
RNA Splicing Factors
/ genetics
RNA, Messenger
/ genetics
Repressor Proteins
/ genetics
Scoliosis
/ genetics
Syndrome
Tumor Suppressor Proteins
/ genetics
Breakpoint cloning
Gene fusion
Intellectual disability
Long-range PCR
Next generation sequencing
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
11
06
2018
revised:
04
10
2018
accepted:
22
11
2018
pubmed:
26
11
2018
medline:
13
3
2020
entrez:
26
11
2018
Statut:
ppublish
Résumé
Expression of the fusion genes is considered to be an important mechanism of tumorigenesis. However it is hardly ever discussed in relation to the neurodevelopmental disorders. Here we report on an 18-years-old female patient with 13.1 kb deletion of 8q24.3 fusing the 5'-portion of SCRIB with the 3'-portion of PUF60 and presenting with borderline intellectual disability, eye coloboma, short stature, scoliosis, heart defects and interestingly postnatal megalencephaly, in contrast to microcephaly, which is usually associated with 8q24.3 deletion (Verheij syndrome). Using next generation sequencing we mapped the breakpoints at nucleotide resolution and showed that the deletion preserved the reading frame. In contrast to the laborious techniques previously used for the precise mapping of deletion breakpoints, our approach identified an accurate interval very rapidly. We demonstrated the expression of the PUF60-SCRIB fusion gene in patient's cells and suggest that the fusion transcript might be a cause of the atypical clinical presentation.
Identifiants
pubmed: 30472487
pii: S1769-7212(18)30367-7
doi: 10.1016/j.ejmg.2018.11.021
pii:
doi:
Substances chimiques
Membrane Proteins
0
RNA Splicing Factors
0
RNA, Messenger
0
Repressor Proteins
0
SCRIB protein, human
0
Tumor Suppressor Proteins
0
poly-U binding splicing factor 60KDa
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103587Informations de copyright
Copyright © 2018. Published by Elsevier Masson SAS.